Provided by Tiger Trade Technology Pte. Ltd.

HORIZON KINETICS MEDICAL ETF

35.24
-0.2499-0.70%
Post-market: 35.250.0137+0.04%16:10 EDT
Volume:732
Turnover:25.84K
Market Cap:16.56M
PE:- -
High:35.25
Open:35.25
Low:35.24
Close:35.49
52wk High:37.90
52wk Low:28.87
Shares:469.95K
Float Shares:469.95K
Volume Ratio:1.05
T/O Rate:0.16%
Dividend:0.41
Dividend Rate:1.16%
ROE:--
ROA:--
PB:--
PE(LYR):- -

Loading ...

Retension Pharmaceuticals, TRex Bio File for US IPO as Biotech Momentum Continues

Reuters
·
14 hours ago

Alkermes Files Form 3 for Director Anne Clem Whitaker`

Reuters
·
15 hours ago

3 ‘Strong Buy’ Dividend Aristocrat Stocks to Generate Steady Cash

TIPRANKS
·
16 hours ago

Sector Update: Healthcare

MT Newswires Live
·
17 hours ago

Eli Lilly reports full FDA approval of Inluriyo combo for certain breast cancers

TIPRANKS
·
18 hours ago

US FDA Approves Lilly Inluriyo-Verzenio Combo for ESR1-Mutated Metastatic Breast Cancer

Reuters
·
18 hours ago

U.S. FDA Approves Inluriyo (Imlunestrant) in Combination with Verzenio (Abemaciclib) for Adults with Er+, Her2-, Esr1-Mutated Advanced or Metastatic Breast Cancer

THOMSON REUTERS
·
18 hours ago

Eli Lilly - Inluriyo with Verzenio NOW Available in the United States

THOMSON REUTERS
·
18 hours ago

Novartis AG Falls Friday, Outperforms Market

Dow Jones
·
20 hours ago

Novartis announces positive CHMP opinion for Cosentyx

TIPRANKS
·
Yesterday

Electra Therapeutics indicated to open at $20, IPO priced at $15

TIPRANKS
·
Yesterday

AbbVie presents new Vraylar data at Psych Congress 2026

TIPRANKS
·
Yesterday

AbbVie Says Real-World Studies Show Vraylar Improves Symptoms in MDD, Bipolar I Depression

Reuters
·
Yesterday

Tellgen Corporation's Subsidiaries Obtain Regulatory Approvals for Two Diagnostic Products

Stock News
·
Yesterday

Analysts Offer Insights on Healthcare Companies: Eli Lilly & Co (LLY), BioMarin Pharmaceutical (BMRN) and Axsome Therapeutics (AXSM)

TIPRANKS
·
Yesterday

All 50 States Sign up for Trump's Medicaid Most-Favored-Nation Plan

Reuters
·
Yesterday

Kaiyuan Securities: Generic Drug Division Sees Recovery in Earnings Growth, With Innovative Drug and CDMO Transition Players Nearing Their Monetization Phase

Stock News
·
Yesterday

朱保国功成身退,39岁刘大平能否引领丽珠穿越转型深水区?

Deep News
·
Yesterday

China Targets First-in-Class Drug Share Above 25% Globally by 2030 Under New Five-Year Plan

Deep News
·
Yesterday

Ten Ministries Unveil 15th Five-Year Plan for Pharmaceutical Industry, Targeting over 20% Annual Growth in Innovative Drug Sector

Stock News
·
Yesterday